The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 23, 2019

Filed:

Mar. 12, 2013
Applicant:

Children's Medical Center Corporation, Boston, MA (US);

Inventors:

John Kheir, Boston, MA (US);

Lindsay Thomson, Cambridge, MA (US);

Andrew Loxley, Bethlehem, PA (US);

Robert Lee, Bethlehem, PA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 33/00 (2006.01); B01F 7/00 (2006.01); B01F 3/04 (2006.01); B01F 3/08 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0026 (2013.01); A61K 33/00 (2013.01); B01F 3/04453 (2013.01); B01F 3/0807 (2013.01); B01F 7/00758 (2013.01);
Abstract

Formulations containing a carrier and microbubbles encapsulating oxygen gas, and methods for making and using the formulations are described herein. The formulations are manufactured by a process which includes high shear homogenization. The resulting microbubble suspension may be centrifuged to further concentrate the microbubbles. The resulting concentrated LOM suspension preferably has an oxygen content ranging from 50 to 99% (vol). Prior to administration to a patient, the viscosity of the LOM suspension may be reduced to the desired viscosity, preferably similar to the viscosity of the patient's blood. The resulting LOM formulation typically has an oxygen concentration ranging from 65 to 80% (vol). The microbubbles are formed from one or more lipids, preferably one or more phospholipids, most preferably DSPC, and preferably also contain one or more stabilizing agents/excipients, preferably cholesterol.


Find Patent Forward Citations

Loading…